The e-Lung score is associated with mortality and a decline in FVC when applied to CT scans at baseline in patients with non-IPF ILD.
New findings point to a 6% decrease in mortality risk for each unit increase in body mass index (BMI). In a review of 14 datasets including 2080 patients with IPF, researchers found that their risk of ...
Please provide your email address to receive an email when new articles are posted on . Within the studied cohort, males had a higher IPF death rate than females. Researchers observed eight industries ...
Boehringer Ingelheim established a presence in idiopathic pulmonary fibrosis years ago with a drug that has become a standard treatment for this serious lung disorder. Now the company has the ...
Interstitial lung disease — either associated with connective-tissue diseases, autoimmune, or metabolic conditions, or of unknown cause as in idiopathic pulmonary fibrosis (IPF) — involves ...
Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people worldwide.
The benefits of pulmonary rehabilitation (PR) and palliative care (PC) as non-pharmacological therapies for people with idiopathic pulmonary fibrosis (IPF) are increasingly being recognised but in the ...
Not intended for UK and US audiences Nerandomilast long-term survival modeling presented at American Thoracic Society (ATS) 2026 and European ...
UNAGI, a deep generative neural network, tracks IPF progression and identifies potential therapies by analyzing cell types and disease-related genes. The model autonomously learns and refines itself, ...
San Francisco: The legendary tabla virtuoso, Ustad Zakir Hussain passed away on Monday in San Francisco at the age of 73. According to a statement from his family, Hussain's death was caused by ...
Please provide your email address to receive an email when new articles are posted on . Both the 18 mg and 9 mg nerandomilast groups had smaller degrees of FVC decline vs. placebo in the U.S. subgroup ...
Chronic cough is common and often debilitating in patients with idiopathic pulmonary fibrosis (IPF), affecting most people ...